Literature DB >> 32913308

Evolocumab reduces LDL-cholesterol levels in FH.

Andrew Robson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32913308     DOI： 10.1038/s41569-020-00448-6

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.

Authors:  Raul D Santos; Andrea Ruzza; G Kees Hovingh; Albert Wiegman; François Mach; Christopher E Kurtz; Andrew Hamer; Ian Bridges; Andrea Bartuli; Jean Bergeron; Tamás Szamosi; Saikat Santra; Claudia Stefanutti; Olivier S Descamps; Susanne Greber-Platzer; Ilse Luirink; John J P Kastelein; Daniel Gaudet
Journal:  N Engl J Med       Date:  2020-08-29       Impact factor: 91.245
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.